MMP9 and neoplasm: Studies have shown LDHC promotes tumor cell invasion and migration by inducing epithelial-mesenchymal transition and the expression of matrix metalloproteinase-9 (MMP9), and this leads to a poor prognosis for tumor patients [17, 18].